Alcaligenes xylosoxidans is non-fermenting gram-negative bacilli found in soil and water. It is an aerobic bacterium in the genus Achromobacter. This bacterium is motile, oxidase positive, and catalase positive, which is isolated uncommonly from clinical specimens. In the present paper, we report a case of meningitis associated with A. xylosoxidans in a 38-year-old male patient post neurosurgery.
Introduction
Alcaligenes xylosoxidans also known as Achromobacter xylosoxidans is an aerobic, motile, oxidase and catalasepositive, non-lactose-fermenting, gram-negative bacillus which is found in soil and water; it is a rare pathogen in human. This organism was briefly classified as genus Alcaligenes, but was recently reclassified as Achromobacter. It was described in 1971 by Yabuuchi and Ohyama [1] , who isolated it from purulent ear discharges from 7 patients with chronic otitis media. A.xylosoxidans has been isolated from a variety of human clinical sources, including blood, cerebrospinal fluid (CSF), sputum, peritoneal fluid, skin, ear discharge, wounds, abscesses, bone, joints, endocardium and central venous catheters [2] [3] [4] [5] [6] [7] [8] [9] .
A. xylosoxidans is an uncommon but serious cause of nosocomial epidemics. Most Alcaligenes infections, are acquired during hospitalization and frequently can be traced to a common source. They have been isolated from respirators, nebulizers and renal dialysis systems [2, 10] , and thus can cause outbreaks in hospitals.
A.xylosoxidans is a rare cause of meningitis. It was reported as a first case report of primary etiological agent of meningitis by Shigeta et al. [8] . Usually, cases of meningitis or ventriculitis caused by A.xylosoxidans were observed to be associated with neurosurgery [8] . However, it is an opportunistic infection and can cause serious problems in humans, especially in immunocompromised patients, such as individuals with HIV/AIDS [11] In the present report, we describe a case of meningitis due to A.xylosoxidans in a neurosurgery patient.
Case Report
A 38-year-old male patient was referred to outpatient neurosurgery on 19 th of January 2007, after reporting an increased headache and memory loss in the previous 15 days with a deviation of the face to right side, seven months following a traffic accident. In neurological examination central facial paralysis and ptosis on his left, hypoesthesia in left V2-V3, reduced hearing were determined.
Computed tomography (CT) of the brain demonstrated a true arachnoid cyst and left temporo-parietal, chronic subdural hemorrhage before the patient underwent surgery (Figure 1) . Magnetic resonance imaging of the brain on admission revealed hemorrhagic arachnoid cyst and subdural effusion ( Figure 2 ). Left side fronto-temporal craniotomy, and removal of the arachnoid cyst wall and fenestration to the basal cisterns were performed. After the operation, the patient was hospitalized in intensive care unit. No additional neurological deficit was determined in his follow-up. On the postoperative third day fever, headache and neck stiffness appeared. The laboratory tests showed leukocytosis (white cell count 14300 /μL) and increased in C reactive protein (7.49 mg/ dl). Cerebrospinal fluid (CSF) was obtained by lumbar puncture. A lumbar puncture revealed cloudy CSF with a protein concentration of 123 mg/dL, and a glucose concentration of 36 mg/dL. Leukocytes of CSF were counted 332/mm 3 on Nageotte counting chamber. Gram stain of the CSF demonstrated many erythrocytes and leukocytes (a differential of 90% neutrophils on Giemsa stain) and ≥1 gram-negative rods per oil-immersion field ( Figure 3) .
The CSF was subcultured on an enriched chocolate agar plate (bioMerieux, France), 5% sheep blood agar plate (bioMerieux, France), brain heart infusion broth (Sigma, USA) and thioglycolate broth (Sigma, USA), and then incubated at 35°C. Smooth colonies consisting of gram-negative rods present on the chocolate agar and 5% sheep blood agar plate after 24 h of incubation. The isolate was nonhemolytic on 5% sheep blood agar ( Figure 4) . It was nonfermentative on triple sugar iron agar, and was positive for catalase, cytochrome oxidase production, and motility. Negative reactions were obtained for hydrogen sulfide on triple sugar iron agar, lysine decarboxylase, and urease. This bacterium was identified twice as A.xylosoxidans with API 32 GN kit (bioMerieux, France).
Antimicrobial susceptibility tests were performed by the disk diffusion method according to the standards of Clinical and Laboratory Standards Institute (CLSI) M100-S17 interpretative criteria. The identified bacterium, Postoperative meningitis due to a rare pathogen; Alcaligenes xylosoxidans A.xylosoxidans, A.xylosoxidans was susceptible to the following: imipenem, meropenem, piperacillin/ tazobactam, piperacillin, ceftazidim, mezlocillin, levofloxacin, and ciprofloxacin. It was resistant to the following: gentamicin, tobramycin, amikacin, aztreonam, and cefepime. The treatment of the patient was changed based on antimicrobial susceptibility of the strain; treatment was started with meropenem. After 5 th of February, the patient began to experience fever and retrograde neck stiffness. No growth was observed in the other CSF specimens. Due to an unsatisfactory fenestration of the basal cisterns, the patient underwent a second neurosurgery in which a low pressure cystoperitoneal shunt system was inserted on 13 February 2007, 8 days after symptoms emerged. However, the body temperature of the patient increased on the second day postoperatively, CSF revealed no growing on microbiological evaluation and close monitoring of the body temperature was stopped on the third day. The clinical condition of the patient improved and he was discharged from the hospital.
Discussion
A.xylosoxidans is not commonly involved in infectious diseases. It is found in the aqueous environment and has been demonstrated as the etiologic agent in otitis media, pneumonia, septicemia, endocarditis, endophthalmitis, meningitis, and peritonitis [1] [2] [3] [4] [5] [6] [7] [8] [9] .
Shigeta et al reported the recovery of A.xylosoxidans from the CSF of 6 patients with ventricular infection after neurosurgical operations [8] . Namnyak et al. [12] described a case of neonatal meningitis caused by A.xylosoxidans in a premature infant. This was the first report of meningitis caused by A.xylosoxidans in a patient who had not undergone neurosurgery. Usually the cases of meningitis or ventriculitis caused by A.xylosoxidans were observed to be associated with neurosurgery [8] .
In the past decade, the recovery of A.xylosoxidans has increased. This increase may be related to an increasing number of immunocompromised patients at risk for the development of invasive infections. Yilmaz et al. [13] described post-ERCP bacteremia caused by A.xylosoxidans in a patient with pancreas cancer. Al-Jasser and Al-Anazi [14] reported A.xylosoxidans bacteremia in a patient with acute lymphoblastic leukemia. Shian-Sen et al. [15] recently reported 40 cases of A.xylosoxidans bacteremia, the majority of whom have underlying diseases, such as malignancies, neutropenia and use of steroids. Cases of meningitis and peritonitis caused by A.xylosoxidans were declared recently in Turkey [16, 17] . Tasdelen-Fisgin et al. reported a case of meningitis in a patient who had a ventriculoperitoneal shunt found during an operation on the shunt [17] . This case of meningitis, caused by A.xylosoxidans, also was reported to have occurred after a neurosurgical operation.
Treatment of infections caused by this organism is usually difficult as multidrug resistance is common and optimal therapy has not yet been determined. Empirical antibiotic therapy with piperacillin-tazobactam or a carbapenem is a reasonable choice until the results of susceptibility tests are available. It's known that A.xylosoxidans is characteristically susceptible to antipseudomonal penicillins, and carbapenems. It is usually resistant to aminoglycosides, ampicillin, aztreonam, and most of the cephalosporins.
In this case, it was shown that A.xylosoxidans was susceptible to imipenem, meropenem, piperacillin/ tazobactam, piperacillin, ceftazidim, mezlocillin, levofloxacin, and ciprofloxacin and resistant to gentamicin, tobramycin, amikacin, aztreonam and cefepime. Based on these results, the patient was treated with meropenem. After 20 days of treatment, the meningitis resulted in cure.
In conclusion, the postoperative meningitis caused by A.xylosoxidans was presented in a 38-year-old man who underwent neurosurgery and later treated. A.xylosoxidans should be considered a rare, but potential pathogen able to produce meningitis in patients who undergo neurosurgery. This case was considered a nosocomial infection. Despite the regular surveillance studies, no other nosocomial infection due to A. xylosoxidans was found. For this reason, the source of this infection was not investigated.
